Novel nanocrystal-based solid dispersion with high drug loading, enhanced dissolution, and bioavailability of andrographolide

References

• Merisko-LiversidgeELiversidgeGGCooperERNanosizing: a formulation approach for poorly-water-soluble compoundsEur J Pharm Sci200318211312012594003
   PubMed Web of Science ®Google Scholar
• KeckCMMüllerRHDrug nanocrystals of poorly soluble drugs produced by high pressure homogenisationEur J Pharm Biopharm200662131616129588
   PubMed Web of Science ®Google Scholar
• YuePFLiYWanJProcess optimization and evaluation of novel baicalin solid nanocrystalsInt J Nanomedicine201382961297323976849
   PubMed Web of Science ®Google Scholar
• BilgiliELiMAfolabiAIs the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS class II drug nanosuspensions?Pharm Dev Technol201621449951025774989
   PubMed Web of Science ®Google Scholar
• KniekeCRawtaniADavéRNConcentrated fenofibrate nanoparticle suspensions from melt emulsification for enhanced drug dissolutionChem Eng Technol2014371157167
   Web of Science ®Google Scholar
• ToziopoulouFMalamatariMNikolakakisIKachrimanisKProduction of aprepitant nanocrystals by wet media milling and subsequent solidificationInt J Pharm2017533232433428257885
   PubMed Web of Science ®Google Scholar
• MalamatariMSomavarapuSTaylorKMBucktonGSolidification of nanosuspensions for the production of solid oral dosage forms and inhalable dry powdersExpert Opin Drug Deliv201613343545026764574
   PubMed Web of Science ®Google Scholar
• ZhangYFengJMcManusSADesign and solidification of fast-releasing clofazimine nanoparticles for treatment of cryptosporidiosisMol Pharm201714103480348828929769
   PubMedGoogle Scholar
• MaYQZhangZZLiGSolidification drug nanosuspensions into nanocrystals by freeze-drying: a case study with ursodeoxycholic acidPharm Dev Technol201621218018825427602
   PubMed Web of Science ®Google Scholar
• AlaeiSGhasemianEVatanaraASpray drying of cefixime nanosuspension to form stabilized and fast dissolving powderPowder Technol2016288241248
   Web of Science ®Google Scholar
• WangYZhengYZhangLStability of nanosuspensions in drug deliveryJ Control Release201317231126114123954372
   PubMed Web of Science ®Google Scholar
• NekkantiVPillaiRVenkateshwarluVHarisudhanTDevelopment and characterization of solid oral dosage form incorporating candesartan nanoparticlesPharm Dev Technol200914329029819235553
   PubMed Web of Science ®Google Scholar
• NiwaTMiuraSDanjoKDesign of dry nanosuspension with highly spontaneous dispersible characteristics to develop solubilized formulation for poorly water-soluble drugsPharm Res20112892339234921626059
   PubMed Web of Science ®Google Scholar
• SarnesAKovalainenMHäkkinenMRNanocrystal-based per-oral itraconazole delivery: superior in vitro dissolution enhancement versus Sporanox is not realized in in vivo drug absorptionJ Control Release201418010911624566254
   PubMed Web of Science ®Google Scholar
• de SmetLSaerensLde BeerTFormulation of itraconazole nanococrystals and evaluation of their bioavailability in dogsEur J Pharm Biopharm201487110711324388913
   PubMed Web of Science ®Google Scholar
• van EerdenbrughBVercruysseSMartensJAMicrocrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions: a case study with itraconazoleEur J Pharm Biopharm200870259059618602992
   PubMed Web of Science ®Google Scholar
• AzadMMorenoJBilgiliEDavéRFast dissolution of poorly water soluble drugs from fluidized bed coated nanocomposites: impact of carrier sizeInt J Pharm20165131–231933127639622
   PubMedGoogle Scholar
• HouYShaoJFuQLiJSunJHeZSpray-dried nanocrystals for a highly hydrophobic drug: increased drug loading, enhanced redispersity, and improved oral bioavailabilityInt J Pharm20175161–237237927880871
   PubMedGoogle Scholar
• LiversidgeGGCundyKCParticle size reduction for improvement of oral bioavailability of hydrophobic drugs – I: absolute oral bioavailability of nanocrystalline danazol in beagle dogsInt J Pharm199512519197
   Web of Science ®Google Scholar
• SuzukiMMachidaMAdachiKHistopathological study of the effects of a single intratracheal instillation of surface active agents on lung in ratsJ Toxicol Sci2000251495510736790
   PubMedGoogle Scholar
• LebhardtTRoeslerSUusitaloHPKisselTSurfactant-free redispersible nanoparticles in fast-dissolving composite microcarriers for dry-powder inhalationEur J Pharm Biopharm2011781909621145394
   PubMed Web of Science ®Google Scholar
• ChinWWParmentierJWidzinskiMTanEHGokhaleRA brief literature and patent review of nanosuspensions to a final drug productJ Pharm Sci2014103102980299925099918
   PubMed Web of Science ®Google Scholar
• KesisoglouFPanmaiSWuYNanosizing: oral formulation development and biopharmaceutical evaluationAdv Drug Deliver Rev2007597631644
   PubMed Web of Science ®Google Scholar
• KimSLeeJEffective polymeric dispersants for vacuum, convection and freeze drying of drug nanosuspensionsInt J Pharm20103971–221822420637852
   PubMedGoogle Scholar
• KhoKHadinotoKEffects of excipient formulation on the morphology and aqueous re-dispersibility of dry-powder silica nanoaggregatesColloids Surf A Physicochem Eng Aspects20103591–37181
   Web of Science ®Google Scholar
• HuJNgWKDongYShenSTanRBContinuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-dryingInt J Pharm20114041–219820421056643
   PubMed Web of Science ®Google Scholar
• HongJLiuYXiaoYHigh drug payload curcumin nanosuspensions stabilized by mPEG-DSPE and SPC: in vitro and in vivo evaluationDrug Deliv201724110912028155567
   PubMed Web of Science ®Google Scholar
• LeeTWBoersenNAHuiHWChowSFWanKYChowAHDelivery of poorly soluble compounds by amorphous solid dispersionsCurr Pharm Des201420330332423651395
   PubMed Web of Science ®Google Scholar
• TianBZhangLPanZGouJZhangYTangXA comparison of the effect of temperature and moisture on the solid dispersions: aging and crystallizationInt J Pharm20144751–238539225218489
   PubMedGoogle Scholar
• OmidianHParkKSwelling agents and devices in oral drug deliveryJ Drug Deliv Sci Technol20081828393
   Web of Science ®Google Scholar
• AgrawalADudhediaMDengWDevelopment of tablet formulation of amorphous solid dispersions prepared by hot melt extrusion using quality by design approachAAPS PharmSciTech201617121423226757898
   PubMed Web of Science ®Google Scholar
• BhakayAAzadMVizzottiEDavéRNBilgiliEEnhanced recovery and dissolution of griseofulvin nanoparticles from surfactant-free nanocomposite microparticles incorporating wet-milled swellable dispersantsDrug Dev Ind Pharm201440111509152223981202
   PubMed Web of Science ®Google Scholar
• ChaulangGPatelPHardikarSKelkarMBhosaleABhiseSFormulation and evaluation of solid dispersions of furosemide in sodium starch glycolateTrop J Pharm Res2009814351
   Web of Science ®Google Scholar
• FujiiMOkadaHShibataYTeramachiHKondohMWatanabeYPreparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidoneInt J Pharm20052931–214515315778052
   PubMedGoogle Scholar
• WangTLiuBZhangWWilsonBHongJSAndrographolide reduces inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuron-glia cultures by inhibiting microglial activationJ Pharmacol Exp Ther2004308397598314718612
   PubMed Web of Science ®Google Scholar
• ShenYChenCChiouWAndrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effectBr J Pharmacol2002135239940611815375
   PubMed Web of Science ®Google Scholar
• PanossianAHovhannisyanAMamikonyanGPharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination kan jang in rats and humanPhytomedicine200775351364
   Google Scholar
• YeLWangTTangLPoor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P-glycoproteinJ Pharm Sci2011100115007501721721007
   PubMed Web of Science ®Google Scholar
• BothirajaCShindeMBRajalakshmiSPawarAPEvaluation of molecular pharmaceutical and in vivo properties of spray-dried isolated andrographolide-PVPJ Pharm Pharmacol200961111465147219903371
   PubMed Web of Science ®Google Scholar
• XuJMaYXieYDesign and evaluation of novel solid self-nanodispersion delivery system for andrographolideAAPS PharmSciTech20171851572158427620195
   PubMed Web of Science ®Google Scholar
• ChenYLiuYXuJDesign and evaluation of nanocomposite microparticles to enhance dissolution and oral bioavailability of andrographolidePowder Technol2018323219229
   Web of Science ®Google Scholar
• QiaoHChenLRuiTFabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfateInt J Nanomedicine2017121033104628223797
   PubMed Web of Science ®Google Scholar
• YuePFLiGDanJXStudy on formability of solid nanosuspensions during solidification – II: novel roles of freezing stress and cryoprotectant propertyInt J Pharm20144751–2354825158243
   PubMedGoogle Scholar
• GuYMaJLiuYChenBYaoSDetermination of andrographolide in human plasma by high-performance liquid chromatography/mass spectrometryJ Chromatogr B Analyt Technol Biomed Life Sci20078541–2328331
   PubMed Web of Science ®Google Scholar
• StevensREGrayVDorantesAGoldLPhamLScientific and regulatory standards for assessing product performance using the similarity factor, f2AAPS J201517230130625669756
   PubMed Web of Science ®Google Scholar
• LeeJDrug nano- and microparticles processed into solid dosage forms: physical propertiesJ Pharm Sci200392102057206814502544
   PubMed Web of Science ®Google Scholar
• BilgiliEAfolabiAA combined microhydrodynamics–polymer adsorption analysis for elucidation of the roles of stabilizers in wet stirred media millingInt J Pharm20124391–219320623018114
   PubMed Web of Science ®Google Scholar
• ShahUAugsburgerLEvaluation of the functional equivalence of crospovidone NF from different sources – I: physical characterizationPharm Dev Technol200161395111247274
   PubMed Web of Science ®Google Scholar
• AzadMAfolabiAPatelNDavéRBilgiliEProduction of colloidal suspensions of superdisintegrants via wet stirred media millingParticuology20141437682
   Google Scholar
• AzadMAfolabiABhakayALeonardiJDavéRBilgiliEEnhanced physical stabilization of fenofibrate nanosuspensions via wet co-milling with a superdisintegrant and an adsorbing polymerEur J Pharm Biopharm20159437238526079832
   PubMed Web of Science ®Google Scholar
• SchulzMFussneggerBBodmeierRAdsorption of carbamazepine onto crospovidone to prevent drug recrystallizationInt J Pharm20103911–216917620214967
   PubMedGoogle Scholar
• KniekeCAzadMAToDBilgiliEDavéRNSub-100 micron fast dissolving nanocomposite drug powdersPowder Technol20152714960
   Web of Science ®Google Scholar
• KimHJChenXDPearceDSurface characterization of four industrial spray dried dairy powders in relation to chemical composition, structure and wetting propertyColloids Surf B Biointerfaces2002263197212
   Web of Science ®Google Scholar
• SouTOrlandoLMcIntoshMPKaminskasLMMortonDAInvestigating the interactions of amino acid components on a mannitol-based spray-dried powder formulation for pulmonary delivery: a design of experiment approachInt J Pharm2011421222022921963471
   PubMed Web of Science ®Google Scholar
• WuWNancollasGHA new understanding of the relationship between solubility and particle sizeJ Solution Chem1998276521531
   Web of Science ®Google Scholar
• LuYQiJDongXZhaoWWuWThe in vivo fate of nanocrystalsDrug Discov Today201722474475028088442
   PubMed Web of Science ®Google Scholar
• ChenCWangLCaoFFormulation of 20(S)-protopanaxadiol nanocrystals to improve oral bioavailability and brain deliveryInt J Pharm20164971–223924726680316
   PubMedGoogle Scholar